Jason Westra

Mr. Jason Westra


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Open access
PDF file
DHDanielle Haslam
Danielle Haslam
GPGina M. Peloso
Gina M. Peloso
MGMélanie Guirette
Mélanie Guirette
FIFumiaki Imamura
Fumiaki Imamura
TBTraci M. Bartz
Traci M. Bartz
NMNicola McKeown
Nicola McKeown
Background: ChREBP (carbohydrate responsive element binding protein) is a transcription factor that responds to sugar consumption. Sugar-sweetened beverage (SSB) consumption and genetic variants in the CHREBP locus have separately been linked to HDL-C (high-density lipoprotein cholesterol) and triglyceride concentrations. We hypothesized that SSB consumption would modify the association between genetic variants in the CHREBP locus and dyslipidemia. Methods: Data from 11 cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (N=63 599) and the UK Biobank (N=59 220) were used to quantify associations of SSB consumption, genetic variants, and their interaction on HDL-C and triglyceride concentrations using linear regression models. A total of 1606 single nucleotide polymorphisms within or near CHREBP were considered. SSB consumption was estimated from validated questionnaires, and participants were grouped by their estimated intake. Results: In a meta-analysis, rs71556729 was significantly associated with higher HDL-C concentrations only among the highest SSB consumers (β, 2.12 [95% CI, 1.16–3.07] mg/dL per allele; P <0.0001), but not significantly among the lowest SSB consumers ( P =0.81; P Diff <0.0001). Similar results were observed for 2 additional variants (rs35709627 and rs71556736). For triglyceride, rs55673514 was positively associated with triglyceride concentrations only among the highest SSB consumers (β, 0.06 [95% CI, 0.02–0.09] ln-mg/dL per allele, P =0.001) but not the lowest SSB consumers ( P =0.84; P Diff =0.0005). Conclusions: Our results identified genetic variants in the CHREBP locus that may protect against SSB-associated reductions in HDL-C and other variants that may exacerbate SSB-associated increases in triglyceride concentrations. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00005133, NCT00005121, NCT00005487, and NCT00000479.

18 August 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
JVJenna Veenstra
Jenna Veenstra
AKAnya Kalsbeek
Anya Kalsbeek
JWJason Westra
Jason Westra
CDCraig Disselkoen
Craig Disselkoen
CSCaren Smith
Caren Smith
NTNathan Tintle
Nathan Tintle
Numerous genetic loci have been identified as being associated with circulating fatty acid (FA) levels and/or inflammatory biomarkers of cardiovascular health (e.g., C-reactive protein). Recently, using red blood cell (RBC) FA data from the Framingham Offspring Study, we conducted a genome-wide association study of over 2.5 million single nucleotide polymorphisms (SNPs) and 22 RBC FAs (and associated ratios), including the four Omega-3 FAs (ALA, DHA, DPA, and EPA). Our analyses identified numerous causal loci. In this manuscript, we investigate the extent to which polyunsaturated fatty acid (PUFA) levels moderate the relationship of genetics to cardiovascular health biomarkers using a genome-wide interaction study approach. In particular, we test for possible gene–FA interactions on 9 inflammatory biomarkers, with 2.5 million SNPs and 12 FAs, including all Omega-3 PUFAs. We identified eighteen novel loci, including loci which demonstrate strong evidence of modifying the impact of heritable genetics on biomarker levels, and subsequently cardiovascular health. The identified genes provide increased clarity on the biological functioning and role of Omega-3 PUFAs, as well as other common fatty acids, in cardiovascular health, and suggest numerous candidate loci for future replication and biological characterization.

27 November 2018 in Biocomputing 2020
Verified
Conference Paper
Open access
PDF file
AGAngela Gasdaska
Angela Gasdaska
DFDerek Friend
Derek Friend
RCRachel Chen
Rachel Chen
JWJason Westra
Jason Westra
MZMatthew Zawistowski
Matthew Zawistowski
NTNathan Tintle
Nathan Tintle
As genetic sequencing becomes less expensive and data sets linking genetic data and medical records (e.g., Biobanks) become larger and more common, issues of data privacy and computational challenges become more necessary to address in order to realize the benefits of these datasets. One possibility for alleviating these issues is through the use of already-computed summary statistics (e.g., slopes and standard errors from a regression model of a phenotype on a genotype). If groups share summary statistics from their analyses of biobanks, many of the privacy issues and computational challenges concerning the access of these data could be bypassed. In this paper we explore the possibility of using summary statistics from simple linear models of phenotype on genotype in order to make inferences about more complex phenotypes (those that are derived from two or more simple phenotypes). We provide exact formulas for the slope, intercept, and standard error of the slope for linear regressions when combining phenotypes. Derived equations are validated via simulation and tested on a real data set exploring the genetics of fatty acids.

5 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
WWWilliam S William
William S William
JWJason Westra
Jason Westra
NTNathan Tintle
Nathan Tintle
PDPrasad Devarshi
Prasad Devarshi
RGRyan W. Grant
Ryan W. Grant
SMSusan Hazels Mitmesser
Susan Hazels Mitmesser
The role that marine omega-3 polyunsaturated fatty acids (PUFAs) may play in reducing the risk for developing depression and/or anxiety is unclear. The present study examined the relationships between plasma levels of total omega-3 PUFAs, docosahexaenoic acid (DHA) and the non-DHA omega-3 PUFAs with medical-record documented depression and/or anxiety (both historical and recent, within the last 12 months) in the UK Biobank. The associations of these outcomes with the reported use of fish oil supplements (FOS) were also examined. Data from 258,354 participants who had data on plasma omega-3 PUFA levels and all covariates were used for the biomarker-based analyses, and data from 468,145 people who reported FOS use at baseline were used in the latter analysis. We found that all three omega-3 PUFA metrics were inversely associated with a history of both depression and anxiety. Specifically, risk for the former outcome was between 15% and 33% lower in Q5 vs Q1, and for the latter outcome, between 19% to 22% lower comparing Q5 with Q1. Risk for recent depression was 29% and 32% lower (Q5 vs Q1) for total omega-3 PUFAs and for non-DHA, respectively. FOS use was associated with a 9-10% lower risk for a history of depression and anxiety, respectively, and a 20% lower risk for recent anxiety. In conclusion, we found evidence that higher levels of omega-3 PUFAs may play a protective role in depression and anxiety.

8 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
NRNathan Ryder
Nathan Ryder
UBUlf Gunnar Bronas
Ulf Gunnar Bronas
JWJason Westra
Jason Westra
JTJieqi Tu
Jieqi Tu
EJEvan De Jong
Evan De Jong
NTNathan Tintle
Nathan Tintle
People in mid-life interact with several different environments during their daily life in-cluding employment, leisure, commuting, and various family responsibilities, a concept defined as activity space. However, little is known about how these activity spaces contrib-ute to individuals’ daily health behavior choices. The Everyday Environments and Expe-riences (E3) study was conducted to explore these relationships. In this paper, we provide a reproducible GPS processing workflow to generate time-weighted exposure measures (activity spaces) inferred from 21 days of continuous GPS monitoring among 340 mid-life adults in Cook County, Illinois (N=340) from the E3 study. Data from waist-mounted GPS devices that recorded one-minute location epochs were aggregated after excluding time spent within an 800-meter buffer around the home. For each epoch, we derived proximity and kernel density measures for eleven food and physical-activity-related location types (e.g., supermarkets, fitness facilities), along with twenty-six environmental context varia-bles (e.g., land use, crime, population density). Time-weighted averages characterized each participant’s typical non-home environmental exposure. After adjustment for envi-ronmental context, age and gender were generally unrelated to activity-space measures. However, Black and Hispanic participants (as compared to White participants) spent less time near both food and physical-activity resources, suggesting systemic inequities in ac-cess beyond neighborhood composition.

27 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
HLHeidi Lai
Heidi Lai
JWJason Westra
Jason Westra
EJEvan De Jong
Evan De Jong
NTNathan Tintle
Nathan Tintle
MBMartha Belury
Martha Belury
WWWilliam S William
William S William
Background: The role of omega-6 polyunsaturated fatty acids (PUFAs), especially linoleic acid (LA) in adiposity remains contested. While clinical interventions suggest improved body composition with higher LA intake, observational evidence is inconsistent, and few studies incorporate repeated measures to examine longitudinal change. Objective: To investigate associations of circulating LA, non-LA omega-6, and total omega-6 PUFAs with adiposity outcomes in the UK Biobank. Methods: Multivariable linear models evaluated cross-sectional and longitudinal associations between omega-6 fatty acid levels and waist circumference (WC), weight, and whole-body fat mass (FM) adjusting for relevant demographic, lifestyle and medical history covariates. Models considered FA levels per interquintile range and by quintiles. Results: Cross-sectionally, higher circulating LA was inversely associated with WC, weight, and FM. Participants in the highest versus lowest quintile of LA had significantly smaller WC [–11.04 (–11.17, –10.91) cm], lower weight [–11.77 (–11.92, –11.62) kg], and lower FM [–7.87 (–7.97, –7.77) kg]. Associations for total omega-6 were generally consistent with those for LA. Conversely, non-LA omega-6 was positively associated with WC [1.46 (1.32, 1.61) cm], weight [2.41 (2.25, 2.58) kg], and FM [1.81 (1.69, 1.92) kg]. Longitudinal analyses largely corroborated these patterns, with annual changes in WC, weight, and FM inversely associated with LA and positively associated with non-LA omega-6. Conclusions: Higher circulating LA, but not non-LA omega-6, was associated with lower WC, weight, and FM both cross-sectionally and longitudinally. Our findings support dietary recommendations to promote LA-rich oils. Divergent associations between LA and non-LA omega-6 caution against treating omega-6 PUFAs as a homogenous group, and there remains a need to examine the distinct health effects of individual non-LA omega-6.